However, while IL‐6 is pro‐tumorigenic supporting cellular proliferation, metastases and survival through mechanisms including activation of the JAK/STAT3 signaling pathways, high levels have been reported to be a poor prognostic marker in cancer.28, 29. The gene discussed is IL6; the disease is cancer.